According to the FDA prescribing information, nausea occurred in 12-24% of patients, diarrhea in 11-17%, vomiting in 5-10%, and constipation in 5-7%, with rates varying by dose
Thus, unlike for MACE, the effect of GLP-1RAs in reducing the risk of HHF has not yet been consistently demonstrated in individual trials
Norris SL, Lee N, Thakurta S, Chan BKS
Hypertension 60 , 757764 (2012)
Be especially cautious (and ask for medical guidance) if you: Are pregnant, trying to conceive, or breastfeeding Have significant liver/kidney disease history Have a history of allergies to B vitamins or injection ingredients Take medications that could interact with high-dose vitamins (your clinician should review this) Lipotropic Injections vs Semaglutide or Tirzepatide If youre deciding between support shots and prescription appetite/weight-management meds, it helps to compare them plainly
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats